1167 Olaparib in combination with inhibitors of ATR/CHK1 pathway leads to increased cell death in ovarian cancer cells sensitive and resistant to PARPi
1167 Olaparib in combination with inhibitors of ATR/CHK1 pathway leads to increased cell death in ovarian cancer cells sensitive and resistant to PARPi